Patents imply intellectual property and it has a $ value that can be associated depending on the field and type of patent that is allocated. Patents also increase the enterprise value of the company and help prevent copy-cats from copying the idea without having royalt payments or licencing deals. We like it when companies get patents awarded!. To protect IP companies aggressively file provisional patents even before they have a working product. The below table provides a way to look at what has been done by companies and use this as a factor to make investment decisions.
| Title | Filing Date | Publication Date | Grant Date |
|---|---|---|---|
| Chimeric antigen receptor spacers | 2022-11-10 | 2023-1-01 | |
| Methods for culturing cells | 2022-10-28 | 2022-12-01 | |
| Novel recombinant cell surface markers | 2022-9-15 | 2022-11-01 | |
| Nr4a-deficient cells expressing c-jun and uses thereof | 2022-6-01 | 2023-2-16 | |
| Nr4a3-deficient immune cells and uses thereof | 2022-5-27 | 2022-12-01 | |
| Nr4a3-deficient cells and uses thereof | 2022-5-27 | 2022-11-28 | |
| Enhanced immune cell therapy targeting ny-eso-1 | 2022-2-25 | 2022-9-01 | |
| Ror1 targeting chimeric antigen receptor | 2022-2-24 | 2022-9-01 | |
| Methods for culturing cells | 2022-2-24 | 2022-9-01 | |
| Codon-optimized nucleotide sequences encoding an ap-1 transcription factor | 2022-2-24 | 2022-9-01 | |
| Improved immune cell therapy | 2022-1-27 | 2022-8-04 | |
| Methods for making, compositions comprising and methods of using rejuvenated t … | 2021-11-24 | 2022-9-16 | |
| Methods for culturing immune cells | 2021-11-23 | 2022-5-27 | |
| Chimeric activation receptors | 2021-10-22 | 2022-4-28 |